Since young and less severely affected DMD patients were more responsive in the intervention, we assessed whether AON, exon skip, and dystrophin levels would differ in the more severely affected DBA/2J-mdx mouse. This evidence concerns the gene DMD and Duchenne muscular dystrophy.